News
Public · Published
Wolfe Research points to upside for MSG Knickerbockers
Wolfe Research upgraded MSG Knickerbockers Corp. from Peer Perform to Outperform and set a $380 price target. Analyst Peter Supino said the firm's stand-alone Knicks estimates include higher operating expenses and new tax payments in FY28, causing cash to dwindle toward zero, while citing rising team value and a likely minority sale.
Published:
Updated:
What happened
Wolfe Research upgraded MSG Knickerbockers Corp. from Peer Perform to Outperform and set a $380 price target. Analyst Peter Supino said the firm’s stand-alone Knicks estimates include higher operating expenses and new tax payments in FY28, causing cash to dwindle toward zero, while citing rising team value and a likely minority sale.
Confirmed
Global impact / market context
The tension is between shrinking cash and a potentially valuable sale of a minority stake. If the Knicks sell part of the team at a high valuation, proceeds could provide cash without more borrowing; that possibility is central to Wolfe’s positive view, but the sale is not confirmed.
Analyst inference
Supino said a minority sale could price the equity at more than 20 times sales, comparable to the Lakers, while MSG Knickerbockers trades at about 11.5 times sales, meaning company value relative to revenue. That gap frames Wolfe’s upside case, not a guaranteed outcome.
Analyst inference
What to watch
- Watch for an announced minority sale, including the stake sold and its price, since those details would show whether the proposed transaction can deliver cash at a premium valuation. Analyst inference
- Track whether higher operating expenses and FY28 tax payments push Knicks cash toward zero as estimated; the article says these pressures are included in Wolfe’s stand-alone forecasts. Confirmed
- Observe any change in borrowing plans: Supino expects the Knicks are unlikely to take on more debt, making a minority sale a possible alternative source of cash. Analyst inference